Baxter International Inc. (BAX)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for BAX is $21.53, 14.8% below the last close of $25.28 on Oct 16, 2026; targets range from $14.79 to $27.37. Rating consensus: Hold.
Snapshot
- P/E—
- P/E vs sector—
- P/E vs own—
- Target upside-14.8%
- ConsensusHold
- Market cap$13.07B
- FCF yield+5.2%
- InsidersNone in 90d
- Earnings in13d
- News0.00
Why it moved
Baxter International Inc. (BAX) fell 1.9% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to BAX.
0 stories on the day (30-day average 0.4).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $25.28 · +10.3% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50↑ in ~8d
- RSI59
- Support-4.0%
- Resistance+7.8%
- Off 52w high-10.8%
- Off ATH-69.8%
- 52w range$25.28
- Bollingerupper half
- MACD0.24
- ATR+2.8%
- Volume0.7x
Analyst price targets
8 firms with a target in the last 12 months · last close $25.28 · as of Oct 16, 2026
Strong buy 1 · Buy 2 · Hold 11 · Sell 0 · Strong sell 1
Revenue and free cash flow
Q2 FY2026: Revenue +5.3% year over year, free cash flow 1.1% of revenue, operating margin 7.3%.
| Q2 FY2026 | Jun 30, 2026 | $2.96B | 0.24 | $32M | 34.9% | 7.3% | 4.3% |
| Q1 FY2026 | Mar 31, 2026 | $2.7B | -0.03 | $76M | 33.0% | 2.4% | -0.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.97B | -2.16 | $444M | 19.4% | -24.5% | -37.9% |
| Q3 FY2025 | Sep 30, 2025 | $2.83B | -0.09 | $126M | 33.5% | 6.1% | -1.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.81B | 0.18 | $68M | 35.3% | 6.8% | 3.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.63B | 0.25 | -$315M | 32.8% | 2.2% | 4.8% |
| Q4 FY2024 | Dec 31, 2024 | $2.75B | -1.00 | $351M | 34.8% | -15.8% | -18.6% |
| Q3 FY2024 | Sep 30, 2024 | $2.7B | 0.27 | $229M | 38.3% | 5.7% | 5.2% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $426.70 | -0.3% | -28.0% | +12.1% | 48.5 | $151B | |
| 2 |  | $191.75 | -1.0% | -1.0% | -6.2% | 57.8 | $52.23B | |
| 3 |  | $238.97 | -1.3% | -12.7% | +3.7% | 23.0 | $33.61B | |
| 4 |  | $384.02 | +0.3% | 0.0% | +1.9% | 49.1 | $27.03B | |
| 5 |  | $85.81 | -2.3% | -7.2% | +3.6% | 10.5 | $14.61B | |
| 6 | | $25.28 | -1.9% | -10.8% | -14.8% | — | $13.07B | |
| 7 |  | $187.31 | -1.0% | -22.3% | +24.2% | 16.5 | $11.95B | |
| 8 |  | $57.94 | +0.9% | -31.3% | +0.9% | 19.8 | $11.02B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.